Peptibase
Hormonal

Desmopressin

Also known as: DDAVP, Stimate, Minirin

FDA Approved
Share:

Popular For

Bedwetting, diabetes insipidus, bleeding disorders

Key Facts: Desmopressin

Category
Hormonal
FDA Status
FDA Approved
Clinical Status
FDA Approved - Multiple indications
Administration
Intranasal, oral, IV, or subcutaneous
Typical Dose
Limited community data available
Frequency
See research protocols
Evidence Level
FDA Approved
Duration
Varies by condition
Also Known As
DDAVP, Stimate, Minirin

Mechanism of Action

Desmopressin selectively activates V2 receptors in the kidneys, promoting water reabsorption without affecting V1 receptors (no blood pressure effects). Also releases von Willebrand factor and Factor VIII for hemostasis.

Research Summary

FDA approved since 1978 with extensive safety record. First-line treatment for central diabetes insipidus. Effective for nocturnal enuresis and certain bleeding disorders. Available in multiple formulations.

Clinical Status:FDA Approved - Multiple indications
Trial Progress:FDA Approved
Pre
I
II
III
IV
FDA

Dosing Information

FDA Approved·Human clinical trials completed, FDA approved

Typical Dosingⓘ

Community experience

Common Dose

Limited community data available

Range

See research dosing

Frequency

See research protocols

Research Dosingⓘ

Scientific studies

FDA-approved dosing varies by indication

Duration

Varies by condition

Administration

Intranasal, oral, IV, or subcutaneous

Timing & Administration

Best Time to Take

Morning or as directed

Follow recommended protocol

Food Recommendation

With or without food

Why This Timing?

Timing may vary based on individual response and goals. Consistency is generally more important than specific timing.

Possible Side Effects

Not everyone experiences these effects. Individual responses vary based on dosage, duration, and personal factors.

  • ●Headache (common)
  • ●HYPONATREMIA (major risk)
  • ●Water intoxication (can cause seizures)
  • ●Nausea
  • ●Nasal congestion (spray)
  • ●Thrombotic events (rare)
  • ●FDA approved (DDAVP)

References

Related Peptides

Peptides commonly compared with Desmopressin or used in similar applications.

Oxytocin

FDA

A naturally occurring peptide hormone crucial for social bonding, childbirth, and lactation. Being studied for autism, anxiety, and social disorders.

Hormonal

Gonadorelin

FDA

A synthetic version of gonadotropin-releasing hormone. Used diagnostically and therapeutically for various reproductive and hormonal conditions.

Hormonal

Leuprolide

FDA

A GnRH agonist that suppresses testosterone and estrogen production. FDA approved for prostate cancer, endometriosis, uterine fibroids, and precocious puberty.

Hormonal

Octreotide

FDA

A synthetic somatostatin analog that inhibits multiple hormones. Used for acromegaly, carcinoid tumors, and various GI conditions.

Hormonal

Lanreotide

FDA

A long-acting somatostatin analog similar to octreotide. FDA approved for acromegaly and gastroenteropancreatic neuroendocrine tumors.

Hormonal

Pasireotide

FDA

A somatostatin analog with broader receptor binding than octreotide. Specifically effective for Cushing's disease due to SST5 activity.

Hormonal
How to Use DesmopressinDesmopressin AlternativesCompare with SimilarBrowse All Peptides

Looking for a trusted vendor?

Pro members get access to verified vendors with quality standards & exclusive discount codes.

View Verified Vendors
PRO

Want updates on Desmopressin research?

Subscribe to get notified when we add new research findings, protocol updates, and related peptide information.

Back to all peptides